May 13, 2020 / 10:13 PM / 20 days ago

BRIEF-Genocea To Present Long-Term Follow-Up Data From Gen-009 Neoantigen Vaccine At Virtual Asco 2020

May 13 (Reuters) - Genocea Biosciences Inc:

* GENOCEA TO PRESENT LONG-TERM FOLLOW-UP DATA FROM GEN-009 NEOANTIGEN VACCINE AT VIRTUAL ASCO 2020

* GENOCEA BIOSCIENCES INC - SEVEN OUT OF EIGHT PATIENTS TREATED ON PART A OF STUDY ARE WITHOUT DISEASE PROGRESSION AT ONE-YEAR MEDIAN FOLLOW-UP Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below